https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(21)00351-9/fulltext
Humoral and cell-mediated immune responses are blunted after SARS-CoV-2 vaccination in patients with a history of CD20 B-cell-depleting treatment.1 However, vaccination induces SARS-CoV-2-specific antibodies in patients treated with rituximab once peripheral …
Create an account or login to join the discussion